TY  - JOUR
A1  - Friedrich-Rust, Mireen
A1  - Wanger, Beate
A1  - Heupel, Florian
A1  - Filmann, Natalie
A1  - Brodt, Hans-Reinhard
A1  - Kempf, Volkhard A. J.
A1  - Kessel, Johanna
A1  - Wichelhaus, Thomas Alexander
A1  - Herrmann, Eva
A1  - Zeuzem, Stefan
A1  - Bojunga, Jörg
T1  - Influence of antibiotic-regimens on intensive-care unit-mortality and liver-cirrhosis as risk factor
T2  - World journal of gastroenterology
N2  - AIM: To assess the rate of infection, appropriateness of antimicrobial-therapy and mortality on intensive care unit (ICU). Special focus was drawn on patients with liver cirrhosis.
METHODS: The study was approved by the local ethical committee. All patients admitted to the Internal Medicine-ICU between April 1, 2007 and December 31, 2009 were included. Data were extracted retrospectively from all patients using patient charts and electronic documentations on infection, microbiological laboratory reports, diagnosis and therapy. Due to the large hepatology department and liver transplantation center, special interest was on the subgroup of patients with liver cirrhosis. The primary statistical-endpoint was the evaluation of the influence of appropriate versus inappropriate antimicrobial-therapy on in-hospital-mortality.
RESULTS: Charts of 1979 patients were available. The overall infection-rate was 53%. Multiresistant-bacteria were present in 23% of patients with infection and were associated with increased mortality (P < 0.000001). Patients with infection had significantly increased in-hospital-mortality (34% vs 17%, P < 0.000001). Only 9% of patients with infection received inappropriate initial antimicrobial-therapy, no influence on mortality was observed. Independent risk-factors for in-hospital-mortality were the presence of septic-shock, prior chemotherapy for malignoma and infection with Pseudomonas spp. Infection and mortality-rate among 175 patients with liver-cirrhosis was significantly higher than in patients without liver-cirrhosis. Infection increased mortality 2.24-fold in patients with cirrhosis. Patients with liver cirrhosis were at an increased risk to receive inappropriate initial antimicrobial therapy.
CONCLUSION: The results of the present study report the successful implementation of early-goal-directed therapy. Liver cirrhosis patients are at increased risk of infection, mortality and to receive inappropriate therapy. Increasing burden are multiresistant-bacteria.
KW  - Intensive care unit
KW  - Sepsis-bundle
KW  - Early goal-directed therapy
KW  - Liver cirrhosis
KW  - Mortality
Y1  - 2016
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/42271
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-422716
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837437
SN  - 1007-9327
SN  - 2219-2840
N1  - Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
VL  - 22
IS  - 16
SP  - 4201
EP  - 4210
PB  - WJG Press
CY  - Beijing
ER  -